Miller, Jamie L <br/><br/>
Detectable Concentrations of Inhaled Tobramycin in Critically Ill Children Without Cystic Fibrosis: Should Routine Monitoring Be Recommended?  [electronic resource] 

 -  Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies  Dec 2017 
 - e615-e620 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1529-7535 
<br/><br/><label>Standard No.: </label>10.1097/PCC.0000000000001362  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Kidney Injury--chemically induced<br/>Administration, Inhalation<br/>Adolescent<br/>Anti-Bacterial Agents--administration & dosage<br/>Child<br/>Child, Preschool<br/>Critical Illness--therapy<br/>Cystic Fibrosis<br/>Drug Monitoring<br/>Female<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Male<br/>Retrospective Studies<br/>Tobramycin--administration & dosage